A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma.

A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma.

http://www.wikidata.org/entity/Q42519441

about

3D conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments The role of interventional radiology in the management of hepatocellular carcinoma Management of recurrent hepatocellular carcinoma after liver transplant 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma.Current management of hepatocellular carcinoma.Risk factors and therapeutic results of early local recurrence after transcatheter arterial chemoembolization Simultaneous injection of autologous mononuclear cells with TACE in HCC patients; preliminary study.Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection.Embolisation of cancer: what is the evidence?Complications of embolization.Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis.Transarterial therapies for hepatocellular carcinoma.Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.Hepatic parenchymal changes following transcatheter embolization and chemoembolization in a rabbit tumor model.Transcatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinoma.Review article: intra-arterial treatments in patients with hepatocellular carcinoma.Pharmacotherapy of hepatocellular carcinoma.Role functioning is associated with survival in patients with hepatocellular carcinoma.Prognostic factors of spontaneously ruptured hepatocellular carcinoma Factors affecting post-embolization fever and liver failure after trans-arterial chemo-embolization in a cohort without background infective hepatitis- a prospective analysis.Predictors of hepatic decompensation after TACE for hepatocellular carcinoma Concurrent hyperglycemia does not influence the long-term prognosis of unresectable hepatocellular carcinomas An implantable rat liver tumor model for experimental transarterial chemoembolization therapy and its imaging features.Influence of transarterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor and basic fibroblast growth factor in rat with Walker-256 transplanted hepatoma: an experimental study.Comparison of transcatheter arterial chemoembolization, laparoscopic radiofrequency ablation, and conservative treatment for decompensated cirrhotic patients with hepatocellular carcinoma.Clinical significance and risk factors of postembolization fever in patients with hepatocellular carcinoma.Impact of cytolysis following transarterial chemoembolization for hepatocellular carcinoma Sorafenib for treatment of hepatocellular carcinoma: a systematic review.Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.Chinese Medicines as an Adjuvant Therapy for Unresectable Hepatocellular Carcinoma during Transarterial Chemoembolization: A Meta-Analysis of Randomized Controlled Trials Liver injury induced by anticancer chemotherapy and radiation therapy.TACE versus TAE as therapy for hepatocellular carcinoma.Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?Hepatocellular carcinoma: A global view.The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma

P2860

Q26851788-61841599-E1E4-406F-8702-E4962E52327D Q26852174-12EAD278-C936-42E3-8E73-EC2F2515E645 Q26996805-C076033B-E7A5-4DD9-BD5B-6C1EA0B4B1C8 Q26997063-707B78D9-367B-4110-9C7E-69ED3272D0F4 Q28392783-598FDAB2-2DF2-4EF4-ADD1-64D2F3E60AEA Q28394414-F5340B51-95C4-4420-ADA6-085133684DB2 Q30479629-DB1C8F85-7DBC-4512-86DE-39B55FCC8599 Q31096586-7D2EE1C2-A4C3-4429-8745-550F8BEA9583 Q33582165-5AB28DBD-5D12-412A-AE59-CC482C82F072 Q33735369-32DB653C-FFAE-4D1E-AD1A-D49EABD9E295 Q33736790-674BD040-D403-4D09-8249-EC4DE374BA52 Q34077181-83785496-8C25-4869-A959-C13ACB08F273 Q34533357-7C858705-A615-4B0F-AA3B-FA42983ECDA0 Q34563459-07A7D996-69C3-4AE6-808B-293D7852A8D4 Q34605318-31368AE0-5702-4FAC-95F8-C588CF71A6C0 Q34628257-A46B1133-867F-4C78-BA5F-809AFDC70E58 Q34647662-1B6E8661-27E4-4EF4-B63E-4D1F3C6ED10E Q34826535-B5201F2D-73B7-4BDE-B36D-1984ABDF6A37 Q34962750-3BC34B0F-762A-4D95-9A9F-CD42C13C825B Q35085720-E9D4B608-4A32-45CA-9994-0001BA0A6A70 Q35145069-C31D968F-BBA6-4922-9EAB-D59163BB4DB9 Q35593957-76036967-23B2-4A72-A09E-12538A3F3AF8 Q35738710-3826F8E5-43E2-4C4E-B8E9-C043367E2CD8 Q35783915-F49CA1D4-14EA-4E97-87D2-4E646DE8098F Q35914711-CDA06849-E284-44FF-AE85-DC2933F33F53 Q36140437-5697D4EE-7788-40CF-8A3C-C19A13F4548A Q36178985-4F7ADB35-5547-4669-8902-6FF0E09D2114 Q36308373-E2A333F8-6D33-4239-8C47-AC51CFA89E72 Q36308821-62BF5C9B-FAFB-4CBB-AE3C-E544C44044BA Q36474281-E61D0B28-BA1A-4F9A-AFB3-A144DF180954 Q36541165-1F931C59-23E3-4FA2-BBC3-D4FDBCDB9D79 Q36582556-F0788E5F-D168-47FF-9637-8700F2BADE32 Q36680204-4C509B20-F788-40C0-8203-B6C97CCCA594 Q36747526-FADA450D-7B40-409B-A5A4-44A49655262F Q37061945-775E4C8C-A8A5-4262-88FC-F64C654EA2C5 Q37067634-3A62576A-931F-4915-B22C-9D12C84445AC Q37300023-66C3CA96-4AD7-4175-AF30-D22BEE50E57B Q37575639-292B145C-C139-4D83-8F1B-7F5C79428712 Q37589349-3F351DFE-9581-4271-AA86-DF0E5E22CA5B Q37590135-D3A260DE-17E9-40EB-9CC6-BEF93EAF51E2

P2860

A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma.

http://www.wikidata.org/entity/Q42519441

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

A prospective study regarding ...... with hepatocellular carcinoma.

@en

A prospective study regarding ...... with hepatocellular carcinoma.

@nl

type

label

A prospective study regarding ...... with hepatocellular carcinoma.

@en

A prospective study regarding ...... with hepatocellular carcinoma.

@nl

prefLabel

A prospective study regarding ...... with hepatocellular carcinoma.

@en

A prospective study regarding ...... with hepatocellular carcinoma.

@nl

P1433

Q42519441-F830B8BF-1035-428E-9DEA-6B3BA5E4CAD9

P1476

Q42519441-31E6F92F-44F9-4639-9F5D-0F3B82FDFEA4

P2093

Q42519441-101E94DB-9B92-43C5-B833-C253AA3FD74F

Q42519441-433AD8BC-25FB-4192-BCF5-793AF6EC8A75

Q42519441-52DE9137-812D-4723-8B21-52BCEC5C2895

Q42519441-B801F59C-E9C5-42F1-AC5E-52C862CE9B99

Q42519441-C0D4CF35-2667-414F-B91A-B178C4A83BE6

P2860

Q42519441-0037910D-EE3E-4042-B8D5-8AE2F778D71B

Q42519441-1D282497-43C1-4B75-BB44-B45C428A939B

Q42519441-4DD39E98-4C05-4B03-858B-E357004ACEC9

Q42519441-5A7F23A3-0542-4DBB-8C60-C19936553745

Q42519441-615038B3-5BEB-46D5-8810-97A51F593FC6

Q42519441-6DEBB4E2-59D8-4839-B208-4399C25E6B2D

Q42519441-75E1B230-7392-4D20-AEA4-1B808ECBC69B

Q42519441-8BEA1D53-6E21-4756-A096-5FDD6ADC9A8D

Q42519441-F88A6496-0F45-404B-AFF7-4BC9035BE5D8

P304

Q42519441-F89BAAC5-79E6-43CC-B862-22D14D0D229F

P31

Q42519441-F13EC56D-D863-4AB7-A74B-A2CDAAC59567

P356

Q42519441-BAFDB52F-4F97-4E99-8AED-31C1560AA856

P407

Q42519441-2418D43D-09C1-48DE-A71C-9C90AEA226E7

P433

Q42519441-055A2C1A-6545-4282-AEE5-F05E6E3F83F6

P478

Q42519441-F4E812DD-6787-444A-A39D-BAA8EE7A6147

P577

Q42519441-AFAAF205-A2A9-4E21-B367-9D99615D08E8

P5875

Q42519441-1A67A12B-5B1B-4A90-87F0-15A87033F7C7

P698

Q42519441-3568E5EC-4A8C-44DF-BAC1-BE091ACD60C6

P921

Q42519441-BF9B2FD6-E158-46EB-9756-5AA347E6241D

P356

P1433

P1476

A prospective study regarding ...... with hepatocellular carcinoma.

@en

P2093

Annie O Chan

http://www.w3.org/2001/XMLSchema#string

Chee-Kin Hui

http://www.w3.org/2001/XMLSchema#string

Ching-Lung Lai

http://www.w3.org/2001/XMLSchema#string

Man-Fung Yuen

http://www.w3.org/2001/XMLSchema#string

Wai-Kuen Tso

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma.

Sonography of gallbladder perforation: a complication of transcatheter hepatic arterial embolization.

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients.

Emphysematous cholecystitis: complication of hepatic artery embolization.

Gallbladder infarction after hepatic artery embolization.

Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials.

Bacterial Infections Associated with Hepatic Arteriography and Transarterial Embolization for Hepatocellular Carcinoma: A Prospective Study

Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience

Transcatheter Arterial Chemoembolization in Inoperable Hepatocellular Carcinoma: Four-year Follow-up

P304

1747-1752

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.10407

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11443756

http://www.w3.org/2001/XMLSchema#string

P698

11920537

http://www.w3.org/2001/XMLSchema#string

P921